bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 29, 2024
Abstract
Patient-derived
organoids
(PDOs)
are
poised
to
become
central
tools
in
clinical
practice,
preemptively
identify
patient
optimal
treatments,
and
drug
discovery,
overcoming
the
limitations
of
cancer
cell
lines.
However,
implementation
PDOs
both
these
settings
has
been
hampered
by
several
bottlenecks
including
sample
requirements,
assay
time
handling
context
high-throughput-based
assays.
We
report
here
development
a
microfluidic-based
device
(
M
icrofluidic
P
latform
for
O
rganoids
culture,
MPO)
that
miniaturises
greatly
simplifies
PDO
cultures
384-plate
format.
Both
retrospective
prospective
studies
demonstrate
its
predictive
value
swift
straightforward
setting.
Obtaining
comprehensive
functional
molecular
information
on
response
drugs
is
becoming
requirement
discovery.
MPO
allows
subcellular
phenotypic
imaging
screenings,
target
engagement
assessment
efficacy
therapies,
alongside
ability
comprehensively
concomitantly
define
genomic,
transcriptomic,
proteomic,
lipidomic
metabolomic
landscape.
In
all,
we
potential
our
platform
impact
practice
generating
relevant
sensitivity
within
frame
could
inform
treatment
decisions
exploration
mechanisms
underlying
compound
resistance
discovery
efforts.
Life Science Alliance,
Journal Year:
2024,
Volume and Issue:
8(2), P. e202402971 - e202402971
Published: Nov. 13, 2024
Cell
plasticity
(CP),
describing
a
dynamic
cell
state,
plays
crucial
role
in
maintaining
homeostasis
during
organ
morphogenesis,
regeneration,
and
trauma-to-repair
biological
process.
Single-cell-omics
datasets
provide
an
unprecedented
resource
to
empower
CP
analysis.
Hematopoiesis
offers
fertile
opportunities
develop
quantitative
methods
for
understanding
CP.
In
this
study,
we
generated
high-quality
lineage-negative
single-cell
RNA-sequencing
under
various
conditions
introduced
working
pipeline
named
scPlasticity
interrogate
naïve
disturbed
of
hematopoietic
stem
progenitor
cells
with
mutational
or
environmental
challenges.
Using
embedding
UMAP
FA,
continuum
development
is
visually
observed
wild
type
where
the
confirms
low
proportion
hybrid
(
P
hc
,
bias
range:
0.4∼0.6)
on
transition
trajectory.
Upon
Tet2
mutation,
driver
leukemia,
treatment
DSS,
inducer
colitis,
increased
was
enhanced.
We
prioritized
several
transcription
factors
signaling
pathways,
which
are
responsible
alterations.
silico
perturbation
suggests
knocking
out
EGR
regulons
pathways
IL-1R1
β-adrenoreceptor
partially
reverses
promoted
by
mutation
inflammation.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 18, 2024
Abstract
Single-cell
sequencing
has
revolutionized
our
understanding
of
cellular
heterogeneity
and
responses
to
environmental
stimuli.
However,
mapping
transcriptomic
changes
across
diverse
cell
types
in
response
various
stimuli
elucidating
underlying
disease
mechanisms
remains
challenging.
Studies
involving
physical
stimuli,
such
as
radiotherapy,
or
chemical
like
drug
testing,
demand
labor-intensive
experimentation,
often
hindering
the
rapid
advancement
mechanistic
insight
discovery.
To
address
this,
we
present
Squidiff,
a
diffusion
model-based
generative
framework
designed
predict
wide
range
changes.
We
demonstrate
Squidiff’s
robustness
scenarios,
including
differentiation,
gene
perturbation,
prediction.
Through
continuous
denoising
semantic
feature
integration,
Squidiff
effectively
learns
transient
states
predicts
high-resolution
landscapes
over
time
conditions.
Furthermore,
applied
model
development
blood
vessel
organoids
neutron
irradiation
growth
factors.
Our
results
that
enables
silico
screening
molecular
landscapes,
facilitating
hypothesis
generation
providing
valuable
insights
for
precision
medicine.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13371 - 13371
Published: Dec. 13, 2024
During
the
last
decade,
artificial
intelligence
(AI)
was
applied
to
nearly
all
domains
of
human
activity,
including
scientific
research.
It
is
thus
warranted
ask
whether
AI
thinking
should
be
durably
involved
in
biomedical
This
problem
addressed
by
examining
three
complementary
questions
(i)
What
are
major
barriers
currently
met
investigators?
suggested
that
during
2
decades
there
a
shift
towards
growing
need
elucidate
complex
systems,
and
this
not
sufficiently
fulfilled
previously
successful
methods
such
as
theoretical
modeling
or
computer
simulation
(ii)
potential
meet
aforementioned
need?
it
recent
well-suited
perform
classification
prediction
tasks
on
multivariate
possibly
help
data
interpretation,
provided
their
efficiency
properly
validated.
(iii)
Recent
representative
results
obtained
with
machine
learning
suggest
may
comparable
displayed
operators.
concluded
play
an
important
role
practice.
Also,
already
other
physics,
combining
conventional
might
generate
further
progress
new
applications,
involving
heuristic
interpretation.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 29, 2024
Abstract
Patient-derived
organoids
(PDOs)
are
poised
to
become
central
tools
in
clinical
practice,
preemptively
identify
patient
optimal
treatments,
and
drug
discovery,
overcoming
the
limitations
of
cancer
cell
lines.
However,
implementation
PDOs
both
these
settings
has
been
hampered
by
several
bottlenecks
including
sample
requirements,
assay
time
handling
context
high-throughput-based
assays.
We
report
here
development
a
microfluidic-based
device
(
M
icrofluidic
P
latform
for
O
rganoids
culture,
MPO)
that
miniaturises
greatly
simplifies
PDO
cultures
384-plate
format.
Both
retrospective
prospective
studies
demonstrate
its
predictive
value
swift
straightforward
setting.
Obtaining
comprehensive
functional
molecular
information
on
response
drugs
is
becoming
requirement
discovery.
MPO
allows
subcellular
phenotypic
imaging
screenings,
target
engagement
assessment
efficacy
therapies,
alongside
ability
comprehensively
concomitantly
define
genomic,
transcriptomic,
proteomic,
lipidomic
metabolomic
landscape.
In
all,
we
potential
our
platform
impact
practice
generating
relevant
sensitivity
within
frame
could
inform
treatment
decisions
exploration
mechanisms
underlying
compound
resistance
discovery
efforts.